← Back to Clinical Trials
Recruiting NCT04738708

NCT04738708 Telegenetics or In-Person Genetic Counselling

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04738708
Status Recruiting
Phase
Sponsor National Cancer Centre, Singapore
Condition Genetic Counselling
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2021-02-01
Primary Completion 2026-10-06

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Patients referred to CGS at NCCS for HBOC or Lynch syndrome pre-test genetic counselling.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2021-02-01 with a primary completion date of 2026-10-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare clinical outcomes (informed choice and genetic counselling outcomes) and cost (provider and patient time, travel, and telehealth platform) between telegenetics and in-person genetic counselling.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 21 years old. * Patients referred to CGS at NCCS for HBOC or Lynch syndrome pre-test genetic counselling. * Able to read and understand the English Language. * Able to consent and agree to be randomized to either telegenetics or in-person genetic counselling. Exclusion Criteria: * Under the age of 21 years old. * Patients who require genetic results urgently. * Cognitive difficulty/ impairment or current psychiatric or physical illness (visual/ hearing/ neurological) which impairs sound judgement and accurate reporting of medical history over video consultation.

Contact & Investigator

Central Contact

Ryan Tan

✉ ryan.shea.tan.y.c@singhealth.com.sg

📞 +65 6436 8000

Principal Investigator

Ryan Tan

PRINCIPAL INVESTIGATOR

National Cancer Centre, Singapore

Frequently Asked Questions

Who can join the NCT04738708 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, studying Genetic Counselling. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04738708 currently recruiting?

Yes, NCT04738708 is actively recruiting participants. Contact the research team at ryan.shea.tan.y.c@singhealth.com.sg for enrollment information.

Where is the NCT04738708 trial being conducted?

This trial is being conducted at Singapore, Singapore.

Who is sponsoring the NCT04738708 clinical trial?

NCT04738708 is sponsored by National Cancer Centre, Singapore. The principal investigator is Ryan Tan at National Cancer Centre, Singapore. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology